Product Information
CLINDAMYCIN-BENZOYL PEROX 1-5% is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.7423 per GM under NDC 68462048619. Its NADAC has been published 380 times since Jun 26, 2019.
FDA first approved this application on Mar 14, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50; 10 mg/g; mg/g
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462048619
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA209252FDA Approved
3/14/2019
TE Code
AB
On Market Since
3/14/2019
Pharmacological Classes
Price Statistics
The NADAC for CLINDAMYCIN-BENZOYL PEROX 1-5% has been published 380 times since Jun 26, 2019, and over the history we have for it it has declined 72.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7423 per GM |
|---|---|
| All-time high | $2.8038 (Feb 12, 2020) |
| All-time low | $0.6901 (Jun 17, 2026) |
| 52-week high | $0.8776 |
| 52-week low | $0.6901 |
| Median price | $0.9820 |
| Average price | $1.2422 |
| Largest weekly change | +35.1% (Jan 18, 2023) |
| Weeks tracked | 380 |
| Tracking since | Jun 26, 2019 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 33% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
clindamycin and benzoyl peroxide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Lincosamide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLINDAMYCIN-BENZOYL PEROX 1-5%?
The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN-BENZOYL PEROX 1-5%, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.7423 per GM (NDC 68462048619), effective Sep 30, 2026.
How has the price of CLINDAMYCIN-BENZOYL PEROX 1-5% changed over time?
Over the history we have for it, the NADAC for CLINDAMYCIN-BENZOYL PEROX 1-5% has declined 72.3%. It has been tracked across 380 weekly CMS publications since Jun 26, 2019.
What are the highest and lowest recorded NADAC prices for CLINDAMYCIN-BENZOYL PEROX 1-5%?
Since Jun 26, 2019, the NADAC for CLINDAMYCIN-BENZOYL PEROX 1-5% has ranged from a low of $0.6901 (Jun 17, 2026) to a high of $2.8038 (Feb 12, 2020), with a median of $0.9820 per GM.
Are there cheaper alternatives to CLINDAMYCIN-BENZOYL PEROX 1-5%?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLINDAMYCIN-BENZOYL PEROX 1-5%, is $0.5007 per GM — about 33% below CLINDAMYCIN-BENZOYL PEROX 1-5%.
Who manufactures CLINDAMYCIN-BENZOYL PEROX 1-5%?
CLINDAMYCIN-BENZOYL PEROX 1-5% (NDC 68462048619) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.